Jun 1, 2021
SYNTAX: PCI, CABG confer similar long-term outcomes for elderly CAD patients
Whether elderly patients with 3-vessel disease (3VD) and/or left main coronary artery disease (LMCAD) underwent percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG) for revascularization, their ten-year rates of all-cause mortality, life expectancy, five-year major adverse cardiac or cerebrovascular events (MACCE), and five-year quality of life (QOL) were comparable, according to results of the SYNTAX Extended Survival study.
Therefore, PCI “might be a reasonable alternative to CABG for elderly patients with 3VD and/or LMCAD,” concluded Masafumi Ono, MD, of University of Amsterdam, Amsterdam, the Netherlands, and fellow SYNTAX Extended Survival investigators.